List of prices of Romilastin (Roplastin)
Romiplostim (Romiplostim) is a biological agent used to treat chronic immune thrombocytopenia (ITP). It mainly activates the thrombopoietin receptor to stimulate the bone marrow to produce more platelets, thus reducing the risk of bleeding. At present, the drug has been officially launched in China and has been successfully included in the national medical insurance directory, which has greatly alleviated the financial pressure on patients.
In the domestic market, the original drug of romigrastim is produced by Amgen, with the trade name "Nplate". The current main specifications are 250micrograms/ and 500micrograms/. According to the latest medical insurance reimbursement policy, patients can receive cost reductions on a proportional basis if they meet the conditions for medical insurance reimbursement. After reimbursement, the actual price paid for each medicine is significantly reduced, generally around 2,000 RMB. The specific price will fluctuate depending on regional policies, hospital pricing and medical insurance levels.

Compared with the previous high import price, the domestic price of Romigrastim is now more affordable, significantly improving its clinical accessibility. In the early years, patients who purchased drugs through overseas channels may have to pay anywhere from RMB 10,000 to RMB 20,000 per pill. Now, when purchased through regular hospitals and supported by medical insurance, not only are the sources of drugs more secure, but patients can also enjoy more economical and convenient treatment services.
In general, with the official launch of romigrastim (roplagrastim) in China and its coverage by medical insurance, its clinical application has become more extensive, effectively improving the treatment level of thrombocytopenic diseases such as ITP. Patients should use medications scientifically under the guidance of professional doctors, pay attention to local medical insurance policy updates, and plan medication plans rationally to obtain the best treatment benefits and financial support.
Reference: https://en.wikipedia.org/wiki/Romiplostim
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)